Zebulun D. Horowitz

Zebulun D. Horowitz

Nessuna posizione attualmente

72 anni
Health Technology
Consumer Services

Profilo

Zebulun D.
Horowitz
joined Savient Pharmaceuticals, Inc. in March 2003 as Senior Vice President and Chief Medical Officer.
Previously, he served as an Executive Director of Global Clinical Research and Development for Novartis Pharmaceuticals, which he joined in 1996.
Dr. Horowitz was Principal Scientist and Medical Director of New Drug Development for Procter & Gamble Pharmaceuticals from 1992 to 1996 and an Associate Professor of Clinical Medicine at the University of Cincinnati College of Medicine from 1989 to 1996.
He was Section Chief and Consultant in Endocrinology, Diabetes and Metabolism for the Veterans Administration Medical Center from 1989 to 1996.
Dr. Horowitz served as an Assistant Professor of Medicine and Assistant Attending Physician at the New York University School of Medicine for the Bellevue Hospital Medical Center from 1983 to 1989 and Attending Physician in Endocrinology, Diabetes and Metabolism for New Gouverneur Hospital from 1982 to 1984.
He received a BA from Reed College in 1974 and an MD from the New York University School of Medicine in June 1978.

Precedenti posizioni note di Zebulun D. Horowitz

SocietàPosizioneFine
SAVIENT PHARMACEUTICALS INC Direttore Tecnico/Scientifico/R&S 19/06/2009
Direttore Tecnico/Scientifico/R&S 01/01/1996
Direttore Tecnico/Scientifico/R&S -
Vedi nel dettaglio l'esperienza di Zebulun D. Horowitz

Formazione di Zebulun D. Horowitz

The Reed Institute Undergraduate Degree
New York University Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Zebulun D. Horowitz

Relazioni

100 +

Relazioni di 1° grado

5

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private3

Health Technology

Health Technology

Health Technology

Vedi le connessioni aziendali
  1. Borsa valori
  2. Insiders
  3. Zebulun D. Horowitz
-40% Proroga eccezionale: i nostri abbonamenti ti guidano verso i migliori investimenti di domani.
APPROFITTANE ORA